医学
原发性醛固酮增多症
卡托普利
逻辑回归
醛固酮
血浆肾素活性
荟萃分析
内科学
肾素-血管紧张素系统
醛固酮增多症
系统回顾
梅德林
研究异质性
合并方差
血压
流行病学
原发性高血压
优势比
内分泌学
数据提取
临床试验
流行
随机对照试验
金标准(测试)
抵抗性高血压
儿科
作者
Sonali S. Shah,Renesa Bhatia,Karanjeet Chauhan,Peter J. Fuller,Jun Yang
标识
DOI:10.1097/hjh.0000000000004488
摘要
BACKGROUND: Current recommendations support measuring plasma renin and aldosterone in all adults with hypertension to detect primary aldosteronism (PA). However, clinical guidelines do not address individuals with low renin (commonly defined as a direct renin concentration <10 mU/l or plasma renin activity <1 ng/ml/h) who do not meet diagnostic criteria for PA and have normal or low aldosterone concentration, a normal aldosterone-to-renin ratio, and/or adequate suppression of aldosterone following salt loading or captopril challenge. This systematic review aimed to estimate the global prevalence of low-renin hypertension, as emerging evidence suggests this group may benefit from treatment distinct from standard antihypertensive therapy. METHODS: The protocol was registered with PROSPERO (CRD42023467251). MEDLINE, Embase, and Cochrane databases were searched for studies reporting renin measurements in hypertension. Two reviewers independently screened studies and extracted data, with disagreements resolved by consensus. Study quality was assessed using the Joanna Briggs Institute tool. Pooled prevalence estimates and heterogeneity were calculated using random-intercept logistic regression and I2 statistics. RESULTS: Of 2745 records identified (1968-2024), 56 studies involving 13 210 participants met inclusion criteria. The pooled prevalence of low-renin hypertension was 32% (95% CI 28-35%; I2 = 94%). Prevalence was higher in studies with >70% Black participants (47% vs. 30%, P = 0.034). In studies with confirmatory testing to exclude PA, the pooled prevalence was 27% (95% CI 25-29%; I2 = 0%). CONCLUSION: Low-renin hypertension affects a substantial proportion of individuals with hypertension, particularly among Black populations. Further research is necessary to guide optimal management.
科研通智能强力驱动
Strongly Powered by AbleSci AI